Lead Optimization in Discovery Drug Metabolism and Pharmacokinetics/Case study: The Hepatitis C Virus (HCV) Protease Inhibitor SCH 503034
about
Lead Optimization in Discovery Drug Metabolism and Pharmacokinetics/Case study: The Hepatitis C Virus (HCV) Protease Inhibitor SCH 503034
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Lead Optimization in Discovery ...... Protease Inhibitor SCH 503034
@ast
Lead Optimization in Discovery ...... Protease Inhibitor SCH 503034
@en
Lead Optimization in Discovery ...... Protease Inhibitor SCH 503034
@nl
type
label
Lead Optimization in Discovery ...... Protease Inhibitor SCH 503034
@ast
Lead Optimization in Discovery ...... Protease Inhibitor SCH 503034
@en
Lead Optimization in Discovery ...... Protease Inhibitor SCH 503034
@nl
prefLabel
Lead Optimization in Discovery ...... Protease Inhibitor SCH 503034
@ast
Lead Optimization in Discovery ...... Protease Inhibitor SCH 503034
@en
Lead Optimization in Discovery ...... Protease Inhibitor SCH 503034
@nl
P2093
P2860
P1476
Lead Optimization in Discovery ...... Protease Inhibitor SCH 503034
@en
P2093
F George Njoroge
Ronald E White
Walter A Korfmacher
P2860
P407
P577
2007-06-26T00:00:00Z